Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Kathy Gately

Clinical Senior Lecturer (Clinical Medicine)
      
Profile Photo

Dr. Kathy Gately

Clinical Senior Lecturer (Clinical Medicine)

 


Dr. Kathy Gately graduated with a BSc from University College Dublin and a PhD from the Department of Biochemistry, National University of Ireland Galway in 2000. During her PhD she spent six months at the University of California Los Angeles. She then worked as a postdoctoral fellow in the Dept. of Haematology where she carried out research on the novel targeted agent Imatinib in CML patients. In 2004, Dr. Gately was appointed as a Clinical Lecturer with Prof. Ken O'Byrne in the Dept. of Clinical Medicine. She was instrumental in the establishment of the Lung Cancer Biobank which supports research and clinical trials within the Translational Oncology Research Group (TORG).The main focus of Dr. Gately's research group is (i) the identification of novel prognostic/predictive biomarkers and therapeutic targets to improve treatment options for patients with cancer (ii) elucidating mechanisms of resistance to targeted therapies, in particular PI3K and EGFR inhibitors (iii) the role of the liquid biopsy in cancer diagnosis and treatment. Dr. Gately delivers lectures to undergraduate students in Molecular Medicine as well as the MSc in Molecular Medicine and Translational Oncology. She is editor of a recent book entitled: "Lung Cancer: A Comprehensive Review" Nova Publishers 2013. Dr. Gately is currently leading a research collaboration with Inflection Biosciences Ltd, an Irish company developing targeted small molecule treatments for cancer. The research examines the effectiveness of a panel of the company's targeted PIM kinase inhibitors in the treatment of thoracic malignancy. In particular, solid tumours that have become resistant to other forms of treatment. This research is supported in part by an Innovation Partnership Program award from Enterprise Ireland (EI).
  Bioinformatics   Biological Sciences   Biology   Biomedical sciences   Biostatistical methods   Breast cancer   Cancer genetics and cell biology including metastasis   Cardiothoracic surgery   Cell Death   Cellular Biology   Clinical genetics   Clinical research, trials   Cytogenetics   Diagnostic bioimaging   Gene targeting in breast cancer   Gene therapy   Gene transcription in human cancer   Genetic/Molecular epidemiology   Genetics   Haemotology   Human genetics   Imaging Techniques   Immunoassays   Instrumentation development   Medical technology   Medicine   Molecular Biology   Molecular Genetics   Monoclonal antibodies   Natural Sciences   Quantitative and molecular genetics   Regulatory methods of gene expression   RNA processing, stability and degradation   Stem Cell Biology   Stem Cell biology and hematopoiesis   Systematic Biology   Therapeutic and Clinical oncology   Tumour immunology and immunotherapy
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
French Basic Basic Basic
German Basic Basic Basic
Irish Medium Medium Medium
Details Date From Date To
AACR
ETOP
BTOG
ESBB
IASLC
ESMO
Irish Thoracic Society (ITS)
ERS
LEWIS, F., WARD, M. P., SAADEH, F. A., O'GORMAN, C., MAGUIRE, P. J., BEIRNE, J. P., KAMRAN, W., IBRAHIM, E., NORRIS, L., KELLY, T., HURLEY, S., HENDERSON, B., KANJUGA, M., O'DRISCOLL, L., GATELY, K., ONER, E., SAINI, V. M., CADOO, K., MARTIN, C., O'LEARY, J. J. & O'TOOLE, S. A., A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomas, European Journal of Surgical Oncology, 2025, Journal Article, PUBLISHED
M Saini, Volga, Oner, Ezgi, Ward, Mark P., Hurley, Sinead, Henderson, Brian David, Lewis, Faye, Finn, Stephen P., Fitzmaurice, Gerard J., O'Leary, John J., O'Toole, Sharon, O'Driscoll, Lorraine, Gately, Kathy, A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer, Molecular Oncology, 2024, Journal Article, PUBLISHED  DOI
Opitz, I. and Bille, A. and Dafni, U. and Nackaerts, K. and Ampollini, L. and de Perrot, M. and Brcic, L. and Nadal, E. and Syrigos, K. and Gray, S.G. and Aerts, J. and Curioni-Fontecedro, A. and RÃŒschoff, J.H. and Monkhorst, K. and Weynand, B. and Silini, E.M. and Bavaghar-Zaeimi, F. and Jakopovic, M. and Llatjos, R. and Tsimpoukis, S. and Finn, S.P. and von der ThÃŒsen, J. and Marti, N. and Dimopoulou, G. and Kammler, R. and Peters, S. and Stahel, R.A. and Falcoz, P.-E. and Brunelli, A. and Baas, P. and Hiltbrunner, A. and Kammler, R. and Ruepp, B. and Tsourti, Z. and Zygoura, P. and Vervita, K. and Andriakopoulou, C. and Stavrou, A. and Haberecker, M. and Dettwiler, S. and Prutek, F. and Mittmann, C. and Vrugt, B. and Friess, M. and Matter, A. and Spichiger-HÀusermann, C. and Kirschner, M.B. and Felley-Bosco, E. and Verbeken, E. and Nafteux, P. and Moons, J. and Peeters, L. and Tiseo, M. and Gnetti, L. and Carbognani, P. and Samarzija, M. and Seiwerth, S. and Cardenal, F. and Lorente, S. and Vamvakaris, I. and Boura, P. and Nur, M.M. and Baird, A.-M. and Barr, M.P. and Cuffe, S. and Gately, K. and ThÃŒsen, J.V.D. and Passani, S., European Epidemiology of Pleural Mesotheliomaâ€"Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database, Journal of Thoracic Oncology, 18, (9), 2023, p1233-1247 , Notes: [cited By 4], Journal Article, PUBLISHED  DOI
Richards, Cathy E. and Elamin, Yasir Y. and Carr, Aoife and Gately, Kathy and Rafee, Shereen and Cremona, Mattia and Hanrahan, Emer and Smyth, Robert and Ryan, Daniel and Morgan, Ross K. and Kennedy, Susan and Hudson, Lance and Fay, Joanna and O†Byrne, Kenneth and Hennessy, Bryan T. and Toomey, Sinead, Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC), International Journal of Molecular Sciences, 24, (13), 2023, Notes: [Cited by: 6; All Open Access, Gold Open Access, Green Open Access], Journal Article, PUBLISHED  DOI
Jan H. Rüschoff, Martina Haberecker, Zoi Tsourti, Kristiaan Nackaerts, Marc de Perrot, Luka Br"i", Ernest Nadal, Sotirios Tsimpoukis, Steven G. Gray, Luca Ampollini, Joachim G.J.V. Aerts, Emanuela Felley"Bosco, Michaela B. Kirschner, Kim Monkhorst, Birgit Weynand, Fatemeh Bavaghar-Zaeimi, Miroslav Samaržija, Roger Llatjos, Stephen P. Finn, Enrico Maria Silini, Jan H. von der Thüsen, Nesa Marti, Karerina Vervita, Roswitha Kammler, Solange Peters, Rolf A. Stahel, Paul Baas, Isabelle Opitz, Rolf A. Stahel, Anita Hiltbrunner, Rosita Kammler, Nesa Marti, Patrick Vagenknecht, Barbara Ruepp, Urania Dafni, Zoi Tsourti, Panagiota Zygoura, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Androniki Stavrou, Jan H. Rüschoff, Martina Haberecker, Susanne Dettwiler, Fabiola Prutek, Christiane Mittmann, Isabelle Opitz, Paul Baas, Isabelle Opitz, Bart Vrugt, Martina Friess, Alessandra Matter, Chloé Spichiger-Häusermann, Paul Baas, Eric Verbeken, Birgit Weyenand, Liesbet M. Peeters, Marcello Tiseo, Enrico Maria Silini, Luigi Ventura, Letizia Gnetti, Paolo Carbognani, Fatemeh B. Zaeimi, Sven Seiwerth, Marko Jakopovi", Enriqueta Felip, Susana Lorente, Konstantinos Syrigos, Ioannis Vamvakaris, Paraskevi Boura, Steven G. Gray, Mutaz Mohammed Nur, Anne"Marie Baird, Nesa Marti, Sinéad Cuffe, Kathy Gately, Joachim G.J.V. Aerts, Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project, Modern Pathology, 35, (12), 2022, p1888 - 1899, p1888-1899 , Journal Article, PUBLISHED  DOI
Bracken-Clarke D, Kapoor D, Baird AM, Buchanan PJ, Gately K, Cuffe S, Finn SP., Vaping and lung cancer - A review of current data and recommendations., Lung cancer (Amsterdam, Netherlands), 153, 2021, p11-20 , Journal Article, PUBLISHED  DOI
Moore, G.; Lightner, C.; Elbai, S.; Brady, L.; Nicholson, S.; Ryan, R.; O'Sullivan, K.E.; O'Byrne, K.J.; Blanco-Aparicio, C.; Cuffe, S.; O'Neill, M.; Heavey, S.; Finn, S.P.; Gately, K. , Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC, Cancers, 13, (9), 2021, p2139-, Journal Article, PUBLISHED  URL
Moore, Gillian and Lightner, Clara and Elbai, Samira and Brady, Lauren and Nicholson, Siobhan and Ryan, Ronan and O†Sullivan, Katie E. and O†Byrne, Kenneth J. and Blanco-Aparicio, Carmen and Cuffe, Sinead and O†Neill, Michael and Heavey, Susan and Finn, Stephen P. and Gately, Kathy, Co-targeting PIM kinase and PI3K/mTOR in NSCLC, Cancers, 13, (9), 2021, Notes: [Cited by: 10; All Open Access, Gold Open Access, Green Open Access], Journal Article, PUBLISHED  DOI
Collins, Denis M. and Madden, Stephen F. and Gaynor, Nicola and AlSultan, Dalal and Le Gal, Marion and Eustace, Alex J. and Gately, Kathy A. and Hughes, Clare and Davies, Anthony M. and Mahgoub, Thamir and Ballot, Jo and Toomey, Sinead and O'Connor, Darran P. and Gallagher, William M. and Holmes, Frankie A. and Espina, Virginia and Liotta, Lance and Hennessy, Bryan T. and O'Byrne, Kenneth J. and Hasmann, Max and Bossenmaier, Birgit and O'Donovan, Norma and Crown, John, Effects of HER family-targeting tyrosine kinase inhibitors on antibody-dependent cell-mediated cytotoxicity in HER2-expressing breast cancer, Clinical Cancer Research, 27, (3), 2021, p807 â€" 818 , Notes: [Cited by: 54; All Open Access, Green Open Access], Journal Article, PUBLISHED  DOI
Toomey S, Carr A, Mezynski MJ, Elamin Y, Rafee S, Cremona M, Morgan C, Madden S, Abdul-Jalil KI, Gately K, Farrelly A, Kay EW, Kennedy S, O'Byrne K, Grogan L, Breathnach O, Morris PG, Eustace AJ, Fay J, Cummins R, O'Grady A, Kalachand R, O'Donovan N, Kelleher F, O'Reilly A, Doherty M, Crown J, Hennessy BT, Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples., Journal of Translational Medicine, 18, (1), 2020, p[1-99] , Journal Article, PUBLISHED  TARA - Full Text  DOI
  

Page 1 of 7
kathy gately, Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer, Scientific Reports, 2020, Journal Article, PUBLISHED
Kathy Gately, Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer, Scientific Reports, 2020, Journal Article, PUBLISHED
Kathy Gately, Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer, Scientific Reports, 2020, Journal Article, PUBLISHED
Gaule P, Dasatinib, Cancers, 2019, Journal Article, PUBLISHED
Gately K, Advancing the treatment of non-small cell lung cancer - a combination approach, Cancer Professional, 2018, Journal Article, PUBLISHED
Kathy Gately, Lung Cancer : A Comprehensive Overview, First, New York U.S., Nova Science Publishers Inc, 2013, Book, PUBLISHED